Literature DB >> 31657633

Reconsidering the Optimal Immune Response to Mycobacterium tuberculosis.

Liku B Tezera1, Salah Mansour1,2, Paul Elkington1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31657633      PMCID： PMC7049929          DOI： 10.1164/rccm.201908-1506PP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  60 in total

Review 1.  Tuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosis.

Authors:  Robert L Hunter
Journal:  Tuberculosis (Edinb)       Date:  2016-01-02       Impact factor: 3.131

2.  BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis.

Authors:  Eva Kaufmann; Joaquin Sanz; Jonathan L Dunn; Nargis Khan; Laura E Mendonça; Alain Pacis; Fanny Tzelepis; Erwan Pernet; Anne Dumaine; Jean-Christophe Grenier; Florence Mailhot-Léonard; Eisha Ahmed; Jad Belle; Rickvinder Besla; Bruce Mazer; Irah L King; Anastasia Nijnik; Clinton S Robbins; Luis B Barreiro; Maziar Divangahi
Journal:  Cell       Date:  2018-01-11       Impact factor: 41.582

3.  Mitochondrial cyclophilin D regulates T cell metabolic responses and disease tolerance to tuberculosis.

Authors:  Fanny Tzelepis; Julianna Blagih; Nargis Khan; Joshua Gillard; Laura Mendonca; Dominic G Roy; Eric H Ma; Philippe Joubert; Russell G Jones; Maziar Divangahi
Journal:  Sci Immunol       Date:  2018-05-11

4.  The role of the granuloma in expansion and dissemination of early tuberculous infection.

Authors:  J Muse Davis; Lalita Ramakrishnan
Journal:  Cell       Date:  2009-01-09       Impact factor: 41.582

Review 5.  Tuberculosis--advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers.

Authors:  Robert S Wallis; Markus Maeurer; Peter Mwaba; Jeremiah Chakaya; Roxana Rustomjee; Giovanni Battista Migliori; Ben Marais; Marco Schito; Gavin Churchyard; Soumya Swaminathan; Michael Hoelscher; Alimuddin Zumla
Journal:  Lancet Infect Dis       Date:  2016-04       Impact factor: 25.071

Review 6.  Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses.

Authors:  Anne Lenaerts; Clifton E Barry; Véronique Dartois
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

7.  Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments.

Authors:  Rafael Di Marco Barros; Natalie A Roberts; Robin J Dart; Pierre Vantourout; Anett Jandke; Oliver Nussbaumer; Livija Deban; Sara Cipolat; Rosie Hart; Maria Luisa Iannitto; Adam Laing; Bradley Spencer-Dene; Philip East; Deena Gibbons; Peter M Irving; Pablo Pereira; Ulrich Steinhoff; Adrian Hayday
Journal:  Cell       Date:  2016-09-15       Impact factor: 41.582

Review 8.  Beyond Killing Mycobacterium tuberculosis: Disease Tolerance.

Authors:  Maziar Divangahi; Nargis Khan; Eva Kaufmann
Journal:  Front Immunol       Date:  2018-12-19       Impact factor: 7.561

9.  Human autoreactive T cells recognize CD1b and phospholipids.

Authors:  Ildiko Van Rhijn; Twan van Berlo; Tamara Hilmenyuk; Tan-Yun Cheng; Benjamin J Wolf; Raju V V Tatituri; Adam P Uldrich; Giorgio Napolitani; Vincenzo Cerundolo; John D Altman; Peter Willemsen; Shouxiong Huang; Jamie Rossjohn; Gurdyal S Besra; Michael B Brenner; Dale I Godfrey; D Branch Moody
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

10.  Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.

Authors:  Michele D Tameris; Mark Hatherill; Bernard S Landry; Thomas J Scriba; Margaret Ann Snowden; Stephen Lockhart; Jacqueline E Shea; J Bruce McClain; Gregory D Hussey; Willem A Hanekom; Hassan Mahomed; Helen McShane
Journal:  Lancet       Date:  2013-03-23       Impact factor: 79.321
View more
  6 in total

1.  Tissue-resident-like CD4+ T cells secreting IL-17 control Mycobacterium tuberculosis in the human lung.

Authors:  Paul Ogongo; Liku B Tezera; Amanda Ardain; Shepherd Nhamoyebonde; Duran Ramsuran; Alveera Singh; Abigail Ng'oepe; Farina Karim; Taryn Naidoo; Khadija Khan; Kaylesh J Dullabh; Michael Fehlings; Boon Heng Lee; Alessandra Nardin; Cecilia S Lindestam Arlehamn; Alessandro Sette; Samuel M Behar; Adrie Jc Steyn; Rajhmun Madansein; Henrik N Kløverpris; Paul T Elkington; Alasdair Leslie
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 19.456

Review 2.  Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity.

Authors:  Kanak Parmar; Afzal Siddiqui; Kenneth Nugent
Journal:  Am J Med Sci       Date:  2021-03-08       Impact factor: 2.378

3.  Aggregated Mycobacterium tuberculosis Enhances the Inflammatory Response.

Authors:  Hylton E Rodel; Isabella A T M Ferreira; Carly G K Ziegler; Yashica Ganga; Mallory Bernstein; Shi-Hsia Hwa; Kievershen Nargan; Gila Lustig; Gilla Kaplan; Mahdad Noursadeghi; Alex K Shalek; Adrie J C Steyn; Alex Sigal
Journal:  Front Microbiol       Date:  2021-12-02       Impact factor: 6.064

Review 4.  Understanding the tuberculosis granuloma: the matrix revolutions.

Authors:  Paul Elkington; Marta E Polak; Michaela T Reichmann; Alasdair Leslie
Journal:  Trends Mol Med       Date:  2021-12-15       Impact factor: 11.951

5.  T Cell Receptor Repertoire Analysis Reveals Signatures of T Cell Responses to Human Mycobacterium tuberculosis.

Authors:  Ming-Ming Shao; Feng-Shuang Yi; Zhong-Yin Huang; Peng Peng; Feng-Yao Wu; Huan-Zhong Shi; Kan Zhai
Journal:  Front Microbiol       Date:  2022-02-07       Impact factor: 5.640

6.  Integrated transcriptomic analysis of human tuberculosis granulomas and a biomimetic model identifies therapeutic targets.

Authors:  Michaela T Reichmann; Liku B Tezera; Andres F Vallejo; Milica Vukmirovic; Rui Xiao; James Reynolds; Sanjay Jogai; Susan Wilson; Ben Marshall; Mark G Jones; Alasdair Leslie; Jeanine M D'Armiento; Naftali Kaminski; Marta E Polak; Paul Elkington
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.